Building Blocks
Sous-catégories appartenant à la catégorie "Building Blocks"
- Acides boroniques et dérivés de l'acide boronique(5.784 produits)
- Building Blocks Chiraux(1.242 produits)
- Building Blocks Hydrocarbonés(6.105 produits)
- Building Blocks organiques(61.061 produits)
205399 produits trouvés pour "Building Blocks"
cis-3-amino-1-methylcyclobutanecarboxylic acid hcl
CAS :Versatile small molecule scaffoldFormule :C6H12ClNO2Degré de pureté :Min. 95%Masse moléculaire :165.62 g/mol1,1-Difluoro-5-azaspiro[2.3]hexane hydrochloride
CAS :Versatile small molecule scaffold
Formule :C5H8ClF2NDegré de pureté :Min. 95%Masse moléculaire :155.6 g/mol3-Ethenylazetidine; trifluoroacetic acid
CAS :Versatile small molecule scaffoldFormule :C7H10F3NO2Degré de pureté :Min. 95%Masse moléculaire :197.16 g/mol(3-methylpyrrolidin-3-yl)methanamine dihydrochloride
CAS :Versatile small molecule scaffoldFormule :C6H16Cl2N2Degré de pureté :Min. 95%Masse moléculaire :187.11 g/mol3-(((tert-Butoxycarbonyl)amino)methyl)cyclobutanecarboxylic acid
CAS :Versatile small molecule scaffoldFormule :C11H19NO4Degré de pureté :Min. 95%Masse moléculaire :229.3 g/molN-(4-Aminobicyclo[2.2.1]hept-1-yl)carbamic Acid 1,1-Dimethylethyl Ester
CAS :Versatile small molecule scaffold
Formule :C12H22N2O2Degré de pureté :Min. 95%Masse moléculaire :226.32 g/mol(1S)-1-(3-Methylphenyl)ethan-1-amine hydrochloride
CAS :Versatile small molecule scaffoldFormule :C9H14ClNDegré de pureté :Min. 95%Masse moléculaire :171.67 g/mol(2S,4R)-4-Ethoxypyrrolidine-2-carboxylic acid hydrochloride
CAS :Versatile small molecule scaffoldFormule :C7H14ClNO3Degré de pureté :Min. 95%Masse moléculaire :195.6 g/mol4-Methoxy-4-oxobutanoic acid
CAS :Succinic acid monomethyl ester (SAMME) is an antimicrobial agent that inhibits the enzyme activities of succinate dehydrogenase, producing mitochondrial membrane depolarization and neuronal death. SAMME has been shown to be effective in treating syncytial virus infection and solid tumours, although it has not been studied in depth. The biological sample used for this study was water vapor, which is a substrate molecule for the enzyme succinic acid semialdehyde dehydrogenase (SASD). This enzyme converts SAMME to succinic acid, which can then inhibit phosphofructokinase-1 or pyruvate kinase, leading to cellular necrosis.
Formule :C5H8O4Degré de pureté :Min. 95%Masse moléculaire :132.11 g/mol4-Sulfophthalic acid (contains 3-sulfophthalic acid), 50% aqueous solution
CAS :Please enquire for more information about 4-Sulfophthalic acid (contains 3-sulfophthalic acid), 50% aqueous solution including the price, delivery time and more detailed product information at the technical inquiry form on this page
Formule :C8H6O7SDegré de pureté :80%Masse moléculaire :246.2 g/mol3'-O-Sulfate-epicatechin ammonium
CAS :Please enquire for more information about 3'-O-Sulfate-epicatechin ammonium including the price, delivery time and more detailed product information at the technical inquiry form on this page
Formule :C15H14O9S•NH3Degré de pureté :90%MinMasse moléculaire :387.36 g/molSulfabenzamide
CAS :Sulfabenzamide is a sulfa drug that has been used in the treatment of infectious diseases. It inhibits microbial growth by inhibiting synthesis of folic acid, which is essential for bacterial growth. Sulfabenzamide has been shown to have antimicrobial effects against a number of microorganisms, including several Gram-positive and Gram-negative bacteria. This drug also has anti-inflammatory properties and can be used in the treatment of bowel disease, such as ulcerative colitis. Sulfabenzamide is used to treat choroidal neovascularization in patients with age-related macular degeneration. This drug binds to glycol esters on the surface of human erythrocytes and can be extracted using dispersive solid-phase extraction (DSPE). The DSPE extract was analyzed by a LC-MS/MS method and found to contain sulfabenzamide and sulfadiazine.Formule :C13H12N2O3SDegré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :276.31 g/molN-Succinimdyl-N-methylcarbamate
CAS :N-Succinimdyl-N-methylcarbamate is a reactive, antimicrobial agent that inhibits the activity of an enzyme in the cycle of cellular respiration. It binds to the active site of the enzyme, preventing it from functioning. N-Succinimdyl-N-methylcarbamate has been shown to inhibit hepatitis by inducing apoptosis. The drug has a phase transition temperature of approximately -6°C and is stable at higher temperatures. N-Succinimdyl-N-methylcarbamate has been shown to have an inhibitory effect on cyclic peptides, including those found in bacteria such as Helicobacter pylori and Chlamydia trachomatis.
Formule :C6H8N2O4Degré de pureté :Min. 95%Masse moléculaire :172.14 g/molD-Selenocystine
CAS :Selenocystine is a non-protein amino acid that belongs to the group of selenoamino acids. Selenocystine is found in plants and microorganisms, where it plays a role in bacterial metabolism. Selenocystine can be synthesized by bacteria from D-glutamate, cysteine, and hydrogen sulfide. It has been shown to have synergistic effects with other compounds such as carbon sources, hydroxyl ions, and subunits. Selenocystine has been shown to inhibit the growth of certain strains of bacteria that are resistant to antibiotics such as penicillin or erythromycin. These effects are mediated through the mitochondrial membrane potential and may also be due to its ability to inhibit microbial respiration.
Formule :C6H12N2O4Se2Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :334.09 g/mol5-Phenoxypyrimidine
CAS :5-Phenoxypyrimidine is a pharmaceutical preparation that is used to treat gastric ulcers. It is a prodrug that is converted in the body to 5-phenylpyrimidin-2,4-dione, which inhibits the formation of salt and alkali in the stomach. 5-Phenoxypyrimidine binds to the active site of H+K+ATPase enzyme, thereby preventing it from transporting hydrogen ions into the gastric mucosa where they cause ulcers. This drug may also reduce the rate of gastric acid secretion and increase the pH of gastric secretions.br>br> 5-Phenoxypyrimidine can be taken with food or water, but should not be taken with milk or dairy products as it will inhibit their absorption. This drug should not be taken by patients who have been shown to have an allergy to pyridines or who are pregnant. Patients taking this drug should avoid alcohol consumption becauseFormule :C10H8N2ODegré de pureté :Min. 95%Masse moléculaire :172.18 g/mol3-Amino-6-cyclopropyl-4-phenylthieno[2,3-b]pyridine-2-carboxamide
CAS :Versatile small molecule scaffoldFormule :C17H15N3OSDegré de pureté :Min. 95%Masse moléculaire :309.4 g/mol4-(Chloromethyl)-5-(5-chlorothiophen-2-yl)-1,2-oxazole
CAS :Versatile small molecule scaffoldFormule :C8H5Cl2NOSDegré de pureté :Min. 95%Masse moléculaire :234.1 g/mol7-Bromo-4-chloro-2-methyl-5H-pyrrolo[3,2-d]pyrimidine
CAS :Versatile small molecule scaffoldFormule :C7H5BrClN3Degré de pureté :Min. 95%Masse moléculaire :246.49 g/molMethyl 1-(3-chloropyridin-2-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylate
CAS :Versatile small molecule scaffoldFormule :C11H7ClF3N3O2Degré de pureté :Min. 95%Masse moléculaire :305.64 g/mol2-(2-Bromopyridin-4-yl)propan-2-ol
CAS :Versatile small molecule scaffoldFormule :C8H10BrNODegré de pureté :Min. 95%Masse moléculaire :216.08 g/mol
